Cipla to Sun Pharma: Nomura rates these 6 pharma stocks, riding the GLP-1 wave, ‘Buy’ 3 weeks agoApril 15, 2026
Novo Nordisk cuts prices of Wegovy by 48% as competition intensifies in India’s weight-loss drug market 1 month agoMarch 31, 2026
Govt cracks down on unauthorised sales of weight-loss drugs after generics hit the market 1 month agoMarch 24, 2026
Alkem, Zydus Life: Nomura’s top picks to bet on Rs 12,000 crore generic Semaglutide opportunity 2 months agoMarch 23, 2026
Sun Pharma to Cipla: 7 pharma stocks gear up for Rs 5,000 cr semaglutide opportunity after patent expiry 2 months agoMarch 20, 2026
Patent expiry to pave way for Semaglutide generics at ‘one-fourth of existing prices’ 2 months agoMarch 17, 2026
Coal India, HAL & ONGC set February 18 as record date: Check dividend amount and payout timelines 3 months agoFebruary 17, 2026
5 ‘Buy’ recommendations by Jefferies in the pharma sector with at least 15% upside- Check full list 5 months agoDecember 12, 2025
Nomura holds Nifty target at 26,140 but shakes up portfolio — Swiggy, Titan and 2 more added; Full list inside 7 months agoOctober 21, 2025
